Skip to content

Effect of Tila Jeerakadi Vataka in Reducing Menstrual Pain

Evaluation of Analgesic Effect of Tila Jeerakadi Vataka in the Management of Dysmenorrhea - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101341
Enrollment
96
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

None listed

Sponsors

Haritha P K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primary and Secondary Dysmenorrhea Diagnosed with USG and pain score VAS greater than or equal to 5

Exclusion criteria

Exclusion criteria: Lactating mothers Current use of oral contraceptives, hormonal therapy or any long term analgesics for menstrual pain Known case of uncontrolled Diabetes mellitus Hb less than 8 gram percentage Known case of malignancy

Design outcomes

Primary

MeasureTime frame
To evaluate the change in intensity of lower abdominal pain in women with dysmenorrhea using VASTimepoint: Daily assessment starting from onset of menstrual pain for 3 to 5 days during a menstrual cycle

Secondary

MeasureTime frame
To assess the impact on symptoms such as low back ache, nausea, headache and fatigue during menstruation Compare the analgesic effect in cases of primary and secondary dysmenorrhea To evaluate improvements in quality of life and daily activity performance during menstruationTimepoint: Daily assessment starting from onset of menstrual pain for 3 to 5 days during a menstrual cycle

Countries

India

Contacts

Public ContactDr Rajitha R Warriar

Government Ayurveda College Tripunithura

drrajithawarriar@gmail.com9947144562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026